Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 7.8B | 8.4B | 7.8B |
Cost of revenue | 4.4B | 4.1B | 4.4B | 4.2B |
Gross profit | 3.8B | 3.7B | 3.9B | 3.7B |
Operating expense | ||||
Research & development | 767M | 731M | 773M | 746M |
Selling general and admin | 1.0B | 991M | 1.2B | 1.0B |
Other operating expenses | 413M | 398M | 451M | 427M |
Operating income | 1.6B | 1.6B | 1.5B | 1.5B |
Non operating interest income | ||||
Income | 135M | 145M | 148M | 183M |
Expense | 114M | 103M | 97M | 106M |
Other income expense | -112M | -35M | -132M | -220M |
Pretax income | 1.5B | 1.6B | 1.4B | 1.3B |
Tax provision | 268M | 316M | 289M | 301M |
Net income | 1.3B | 1.3B | 1.1B | 1.0B |
Basic EPS | 1.3 | 1.3 | 1.1 | 1 |
Diluted EPS | 1.3 | 1.3 | 1.1 | 1.0 |
Basic average shares | 969M | 986M | 997M | 1.0B |
Diluted average shares | 977M | 999M | 1.0B | 1.0B |
EBITDA | 2.0B | 2.0B | 1.9B | 1.9B |
Net income from continuing op. | 1.3B | 1.3B | 1.1B | 1.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |